Literature DB >> 17964230

Liquid chromatographic determination of mycophenolic acid and its metabolites in human kidney transplant plasma: pharmacokinetic application.

Fawzy A Elbarbry1, Ahmed S Shoker.   

Abstract

BACKGROUND AND
OBJECTIVE: Difference in the hydrophilic properties of mycophenolic acid metabolites makes it technically difficult to simultaneously determine their plasma levels in one analytical run. Therapeutic drug monitoring (TDM) for MPA ensures adequate MPA exposure levels to both prevent rejection and avoid related toxicity. One measure limitation for TDM for MPA is the availability of simple, rapid and reproducible method for determination of MPA derivatives.
METHOD: Herein we report a single method to measure MPA and its metabolites using a gradient elution system in less than 10 min. We further tested applicability of our method in both stable and unstable renal transplant recipients with a wide range of levels.
RESULTS: Intra- and inter-day imprecision were less than 8% and 10%, respectively. Accuracy of the estimated concentrations ranges from 90% to 108%.
CONCLUSION: Collectively these data show that the new method is reasonably accurate and precise for the simultaneous determination of MPA and its metabolites in human plasma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964230     DOI: 10.1016/j.jchromb.2007.09.036

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

Review 1.  Clinical mycophenolic acid monitoring in liver transplant recipients.

Authors:  Hao Chen; Bing Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Limited sampling strategy to predict mycophenolic acid area under the curve in pediatric patients with nephrotic syndrome: a retrospective cohort study.

Authors:  Joanna Sobiak; Matylda Resztak; Tomasz Pawiński; Paweł Żero; Danuta Ostalska-Nowicka; Jacek Zachwieja; Maria Chrzanowska
Journal:  Eur J Clin Pharmacol       Date:  2019-06-06       Impact factor: 2.953

3.  Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice.

Authors:  Michael Look; Eric Stern; Qin A Wang; Leah D DiPlacido; Michael Kashgarian; Joe Craft; Tarek M Fahmy
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

4.  Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation.

Authors:  Joanna Sobiak; Matylda Resztak; Maciej Głyda; Paulina Szczepaniak; Maria Chrzanowska
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-07       Impact factor: 2.441

5.  Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry.

Authors:  Vivek Upadhyay; Vikas Trivedi; Gaurang Shah; Manish Yadav; Pranav S Shrivastav
Journal:  J Pharm Anal       Date:  2013-06-12

6.  Validated Simple HPLC-UV Method for Mycophenolic Acid (MPA) Monitoring in Human Plasma. Internal Standardization: Is It Necessary?

Authors:  Paweł K Kunicki; Aleksandra Wróbel
Journal:  Molecules       Date:  2021-11-29       Impact factor: 4.411

7.  The Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid in Children with Nephrotic Syndrome.

Authors:  Joanna Sobiak; Matylda Resztak; Maria Chrzanowska; Jacek Zachwieja; Danuta Ostalska-Nowicka
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.